The pharmaceutical industry is poised for long-term growth due to technological advancements, an aging population, and a robust research and development pipeline, ensuring innovative treatments. Given the industry’s growth prospects, Procaps Group S.A. (PROC), Organon & Co. (OGN) and Amphastar Pharmaceuticals, Inc. (AMPH) might be ideal additions to your watchlists.
Before delving deeper into their fundamentals, let’s discuss what’s happening in the pharma industry.
